Cotinga Pharmaceuticals Inc. Share Price Toronto S.E.
Equities
COT.H
CA22164W1059
Biotechnology & Medical Research
Sales 2018 | - | Sales 2019 | - | Capitalization | 1.61M 2.2M 126M |
---|---|---|---|---|---|
Net income 2018 | -4M -5.46M -312M | Net income 2019 | -2M -2.73M -156M | EV / Sales 2018 | - |
Net cash position 2018 | 40.73K 55.57K 3.18M | Net cash position 2019 | 24.64K 33.62K 1.92M | EV / Sales 2019 | - |
P/E ratio 2018 |
-1.11
x | P/E ratio 2019 |
-0.6
x | Employees | 6 |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 69.18% |
Managers | Title | Age | Since |
---|---|---|---|
Alison D. Silva
PSD | President | 46 | 31/12/14 |
Debi Sanderson
COO | Chief Operating Officer | - | - |
Chief Tech/Sci/R&D Officer | 61 | 11/06/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 30/06/18 | |
John C. Drake
CHM | Chairman | - | 19/02/07 |
Alison D. Silva
PSD | President | 46 | 31/12/14 |
1st Jan change | Capi. | |
---|---|---|
+16.61% | 122B | |
+17.75% | 112B | |
+17.23% | 25.91B | |
-24.11% | 19.33B | |
-18.56% | 16.17B | |
-18.47% | 15.6B | |
-47.75% | 14.65B | |
+57.35% | 14.34B | |
+5.62% | 14B |